Confirmation

EP3153170

METHODS AND USES OF THE QUINOLINE DERIVATIVE ANLOTINIB IN THE TREATMENT OF SOFT TISSUE SARCOMAS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF SAME

  • :
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • :
    5.6.2015
  • :
    13.8.2025
  • :
    15803853.9
  • :
    4.6.2035
  • :
    4.6.2026
  • :
    METHODS AND USES OF THE QUINOLINE DERIVATIVE ANLOTINIB IN THE TREATMENT OF SOFT TISSUE SARCOMAS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF SAME

5.6.2015
13.8.2025
4.6.2026
  • :
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd
  • :
    No. 369 Yuzhou South Road Haizhou District, Lianyungang, Jiangsu 222062, CN
  • :
    Advenchen Laboratories Nanjing Ltd.
  • :
    Room 302, Block A, Pharmaceutical & Biology Incubator Building Entrepreneurship Center Nanjing New & High Tech Zone, Nanjing, Jiangsu 210061, CN
  • :
    ZHANG, Xiquan
  • :
    Lianyungang Jiangsu 222062, CN
  • :
    WANG, Xunqiang
  • :
    Lianyungang Jiangsu 222062, CN
  • :
    ZHAN, Xiaole
  • :
    Lianyungang Jiangsu 222062, CN
  • :
    DAI, Jie
  • :
    Lianyungang Jiangsu 222062, CN
  • :
    TIAN, Xin
  • :
    Lianyungang Jiangsu 222062, CN
  • :
    YANG, Ling
  • :
    Lianyungang Jiangsu 222062, CN
  • :
    201410249705
  • :
    6.6.2014
  • :
    CN
  • :
    CN2015080870
  • :
    5.6.2015
  • :
    A61K 31/4709, A61P 35/00, A61K 9/48